Fitness 'boosts cancer survival chances'

31 March 2015 09:11

A new study has highlighted the cancer-beating benefits of older age fitness

A new study has highlighted the cancer-beating benefits of older age fitness

Older men have been told that regular exercise can help them improve their chances of surviving cancer.

A new report showed that men over 65 years-old could increase their chances of surviving the disease's prostate, bowel or lung versions by nearly a third.

The US study also found that regular exercise lowered the danger of older men being detected with bowel and lung cancer. This did not, however, apply to prostate cancer.

Whether people have survived or are still battling cancer, travellers can still enjoy a holiday with peace of mind. Taking out trusted cancer-related travel insurance can cover items such as medical expenses.

The new study monitored the cardio-respiratory fitness (or CRF) of 14,000 American males aged 65 or over for a period of six and a half years, by studying their general health and treadmill tests.

In this time, some 1,310 of the volunteers were detected as having prostate cancer. A further 200 had lung cancer and 181 bowel cancer.

The study linked high physical activity among over-65s with a reduced lung cancer risk of 55%, and a reduced bowel cancer risk of 44%, in contrast to those with lower CRF results.

There was no such link, however, between older-life prostate cancer and CRF.

For males who suffered from cancer, high older-life CRF was linked to a better chance of surviving the disease by 32%. In addition, it resulted in a 68% increased chance of surviving cardiovascular disease.

Vermont University's Susan Lakoski, who headed the research, said that the study suggests that CRF analysis could play a role in preventing health problems in later life.

Dr Lakoski said she believed that hers was the first research to show that CRF can forecast site-specific cancer prevalence.

She said she now wants similar research to be undertaken on women.

The report was published in the JAMA Oncology journal.

Share this on Facebook Tweet this Share this on LinkedIn Email this